Updates in Molluscum Contagiosum Management Digital Edition

Selected Abstracts from Maui Derm 2023 for Dermatologists Digital Edition

Natural Hair Supplements: Trends and Myths Untangled Digital Edition

2022 Conference Highlights: Acne

NP+PA PERSPECTIVES IN DERMATOLOGY

2022 Conference Highlights: Acne

NP+PA Perspectives in Dermatology: March 2023

Special Bonus Issue—Dermatology NP & PA Workforce Survey: Practice Characteristics and Compensation

ALL DIGITAL EDITIONS →

Category: Pyoderma Gangrenosum

Multiple Facial Lesions of Recalcitrant Pyoderma Gangrenosum Successfully Treated with Adalimumab

May 1, 2019

J Clin Aesthet Dermatol. 2019;12(5):28–32 by Raymond E. Kleinfelder, DO; Nady Hin, DO; Stefanie Cubelli, DO; Allan Snyder, PA-C; Francisco Kerdel, BSc, MBBS; and Brad Glick, DO, MPH Drs. Kleinfelder and

A Second Case of Sunitinib-associated Pyoderma Gangrenosum

August 5, 2010

Steven M. Dean, DO, FACP, RPVI; Matthew Zirwas, MD The Ohio State University, Columbus, Ohio Disclosure: Drs. Dean and Zirwas report no relevant conflicts of interest. Abstract Pyoderma gangrenosum is

Pyoderma Gangrenosum in a Patient with Bruton’s X-linked Agammaglobulinemia: Shared Pathogenesis of Altered Tumor Necrosis Factor Alpha?

May 9, 2008

by Elissa M. Schwartzfarb, BS, Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida; Dot Weir, RN, CWON, CWS, Clinical Director, The Wound Center